Rnd3/RhoE Modulates HIF1α/VEGF Signaling by Stabilizing HIF1α and Regulates Responsive Cardiac Angiogenesis

Xiaojing Yue,Tianbao Yang,Xinjian Lin,Xiangsheng Yang,Xin Yi,Xuejun Jiang,Xiaoyan Li,Tianfa Li,Junli Guo,Yiwu Dai,Jianjian Shi,Lei Wei,Keith A. Youker,Guillermo Torre‒Amione,Ye Yu,Kelsey C. Andrade,Jiang Chang

2016-01-01

Abstract:The insufficiency of compensatory angiogenesis in the heart of hypertension patients contributes to heart failure transition. The HIF1α-VEGF signaling cascade controls responsive angiogenesis. One of the challenges in reprograming the insufficient angiogenesis is to achieve a sustainable tissue exposure to the pro-angiogenic factors, such as HIF1α stabilization. In this study, we identified Rnd3, a small Rho GTPase, as a pro-angiogenic factor participating in the regulation of the HIF1α-VEGF signaling cascade. Rnd3 physically interacted with and stabilized HIF1α, and consequently promoted VEGFA expression and endothelial cell tube formation. To demonstrate this pro-angiogenic role of Rnd3 in vivo, we generated Rnd3 knockout mice. Rnd3 haploinsufficient (Rnd3+/−) mice were viable, yet developed dilated cardiomyopathy with heart failure after transverse aortic constriction stress. The post-stress Rnd3+/− hearts showed significantly impaired angiogenesis and decreased HIF1α and VEGFA expression. The angiogenesis defect and heart failure phenotype were partially rescued by cobalt chloride treatment, a HIF1α stabilizer, confirming a critical role of Rnd3 in stress-responsive angiogenesis. Furthermore, we generated Rnd3 transgenic mice and demonstrated that Rnd3 overexpression in heart had a cardio-protective effect through reserved cardiac function and preserved responsive angiogenesis after pressure overload. Finally, we assessed the expression levels of Rnd3 in the Correspondence to: Jiang Chang, MD, PhD; jchang@ibt.tamhsc.edu; Phone: (713) 677-7603, Fax: (713) 677-7410, Mailing address: Texas A&M University Health Science Center, Institute of Biosciences and Technology, 2121 W. Holcombe Blvd., Houston, TX 77030. †These authors contributed equally to this work. Disclosure None. HHS Public Access Author manuscript Hypertension. Author manuscript; available in PMC 2017 March 01. Published in final edited form as: Hypertension. 2016 March ; 67(3): 597–605. doi:10.1161/HYPERTENSIONAHA.115.06412. A uhor M anscript